ChemoCentryx Announces Completion of Target Enrollment of CCX140 Phase II Clinical Trial in Diabetic Nephropathy
MOUNTAIN VIEW, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI) announced that it has completed the target enrollment of 270 patients in a Phase II clinical trial in diabetic nephropathy with CCX140, an inhibitor of the chemokine receptor known as CCR2 and the Company's lead wholly owned drug candidate. Enrollment will be closed by June 30, 2013, at which time ChemoCentryx expects total enrollment to exceed 300 patients in the randomized, double-blind, placebo-controlled study.
Biodel Prices Public Offering of Common Stock
DANBURY, Conn., June 19, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced the pricing of an underwritten public offering of 4,482,760 shares of its common stock at a public offering price of $4.35 per share. All of the shares are being sold by Biodel. The offering is expected to close on June 24, 2013, subject to customary closing conditions. Biodel has also granted the underwriters a 30-day option to purchase up to an additional 672,414 shares to cover overallotments, if any.
Diamondback Energy, Inc.
Diamondback Energy Announces Pricing of Secondary Common Stock Offering
MIDLAND, Texas, June 19, 2013 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (Nasdaq:FANG) ("Diamondback Energy") today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock by certain selling stockholders at a price of $34.75 per share. The 6,000,000 share offering represents a 1,000,000 share upsize to the originally proposed 5,000,000 share offering. The underwriters have an option to purchase up to an additional 869,222 shares from the selling stockholders at the public offering price (less the underwriting discount). The shares to be sold in the offering will be sold by certain entities controlled by Wexford Capital LP and by Gulfport Energy Corporation (Nasdaq:GPOR) ("Gulfport Energy"). All of the net proceeds will go to the selling stockholders.
NASDAQ OMX Tallinn
Resumption of trading in Järvevana shares
Trading in AS Järvevana shares (JRV1T) will be resumed today, on June 19, 2013
at 15.25 EET.
Trading will start with call interaction (CLIN) from 15.15-15.25 EET.
+372 640 8800
FormPipe Software AB
FormPipe Software på stort ramavtal för e-arkiv
FormPipe Software är utvald som leverantör på SKL Kommentus Inköpscentrals
(SKI) ramavtal för e-arkiv. Ramavtalet gäller för fyra år och ramavtalets volym
uppskattas av SKI till cirka 250 Mkr. Den uppskattade volymen inkluderar inte
Över 500 parter från kommuner, landsting, regioner och deras bolag är
avropsberättigade på ramavtalet e-arkiv 2013. Ramavtalet är uppdelat i två
delområden, e-arkiv som produkt och e-arkiv som tjänst.
På delområde e-arkiv so
Ruling by the Circuit Court in criminal matter no. 1-09-4486
With the ruling by the Circuit Court of Tallinn of 19/06/2013, the acquittal by
Harju County Court of 19/06/2012 in criminal matter no. 1-09-4486 (see Stock
annulled and AS Järvevana was found guilty, under Article 298 (4) of the Penal
Code, and the company was ruled to pay a pecuniary punishment on the amount of
798,000 (seven hundred ninety eight thousand) EUR.
Gunnebo Seals Brazilian Cash Handling Order
The Gunnebo Security Group has received its first major order for cash handling
solutions in Brazil from retail chain, Riachuelo. This is a major breakthrough
and is in line with Gunnebo’s strategy to expand the current Brazilian business
and enter into new business sectors.
The order is for Intelisafe, a smart safe solution for the depositing of cash
from tills. Intelisafe gives the retailer control and reconciliation,
transparent transactions, real-time monitoring, improved tracking and follow